Abilify Intramuscular and Mogamulizumab-kpkc Intravenous
Determining the interaction of Abilify Intramuscular and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Abilify MyCite, Aristada Initio
Synonyms: Abilify
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abilify Intramuscular-Molindone
- Abilify Intramuscular-Mometasone (Oral Inhalation)
- Abilify Intramuscular-Mometasone and Formoterol
- Abilify Intramuscular-Mometasone and formoterol Inhalation
- Abilify Intramuscular-Mometasone Cream
- Abilify Intramuscular-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Abilify Maintena
- Mogamulizumab-kpkc Intravenous-Abilify Maintena injection
- Mogamulizumab-kpkc Intravenous-Abilify MyCite
- Mogamulizumab-kpkc Intravenous-Abiraterone
- Mogamulizumab-kpkc Intravenous-Abiraterone acetate
- Mogamulizumab-kpkc Intravenous-Abiraterone Acetate (Yonsa)